At Guardant Health, ESG is at the core of our organization because we are focused on saving lives and improving human health. Our ESG strategy is underpinned by the following six commitments:
- Providing meaningful work and development opportunities to our employees
- Striving to recruit, hire, and retain a talented and diverse team of people who align with our values and fostering a diverse, inclusive, and equitable workplace
- Conducting our business with the highest professional and ethical standards and operating with integrity and mutual respect
- Maintaining a well-developed environmental, health, and safety program, which is reinforced through rigorous policies, education, and engagement of our employees and internal and external periodic audits
- Making it easy and affordable to complete our tests
- Investing in environmental sustainability and responsible supply chain operations
Our inaugural ESG report provides more details about these six commitments and other key ESG issues specific to our business. We identified these topics after analyzing external reporting frameworks, such as the Sustainability Accounting Standards Board (SASB) standards, peer company ESG practices, third-party rating agency assessments, and input from investors, customers, and other stakeholders.
In May 2024, we released an ESG report update offering data and progress updates related to some key topics and initiatives discussed in our 2023 ESG report. Through this supplemental report, we aim to reinforce our dedication to transparency, sustainability, and continuous improvement while demonstrating our efforts to integrate ESG principles into our business operations.
“Our goal from day one has been to provide tests for patients at all stages of cancer so they can live longer and healthier lives. We believe that to serve patients well, it is important to also act responsibly in our relationships with our employees, our communities, and the environment. This inaugural report details our current ESG initiatives and recent achievements, such as our efforts to promote diversity and inclusion across our workforce and in our clinical trials.”
– Helmy Eltoukhy, Guardant Health co-founder and co-CEO.